Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Melatonin for Migraine Prevention (MMP)

This study has been completed.
University of Tromso
Information provided by (Responsible Party):
Karl B. Alstadhaug, Nordlandssykehuset HF Identifier:
First received: February 23, 2009
Last updated: September 24, 2014
Last verified: September 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)